Showing 101–125 of 238 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | Cancer Control ISSN: 1073-2748 / 1526-2359 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.1 | 0.907Q1 | 66 | 133 | 4% | H. Lee Moffitt Cancer Center and Research Institute | Profile |
| 102 | Future Oncology ISSN: 1479-6694 / 1744-8301 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 3.1 | 1.229Q1 | 60 | 390 | 3.3% | Future Medicine Ltd. | Profile |
| 103 | Journal of Immunotherapy and Precision Oncology ISSN: 2666-2345 / 2590-017X | 🌐International | Q3 | CAS Tier 4 | 3.1 | 1.37Q1 | — | 6 | N/A | Innovative Healthcare Institute | Profile |
| 104 | Cancer Epidemiology ISSN: 1877-7821 / 1877-783X | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3 | 1.036Q2 | 68 | 144 | 4.2% | Elsevier BV | Profile |
| 105 | Expert Review of Anticancer Therapy ISSN: 1473-7140 / 1744-8328 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3 | 0.84Q2 | 59 | 99 | 0% | Taylor and Francis Ltd. | Profile |
| 106 | International Journal of Clinical Oncology ISSN: 1341-9625 / 1437-7772 | 🇯🇵Japan | Q3 | CAS Tier 3 | 3 | 0.945Q1 | 53 | 239 | 0% | Springer Singapore | Profile |
| 107 | Journal of Geriatric Oncology ISSN: 1879-4068 / 1879-4076 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.9 | 0.943Q2 | 27 | 187 | 16.7% | Elsevier Ltd | Profile |
| 108 | Hereditary Cancer in Clinical Practice ISSN: 1731-2302 / 1897-4287 | 🌐Poland | Q3 | CAS Tier 3 | 2.8 | 1.049Q2 | 21 | 45 | 5% | BioMed Central | Profile |
| 109 | World Journal of Surgical Oncology ISSN: 1477-7819 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.761Q1 | 48 | 341 | 4% | BioMed Central | Profile |
| 110 | Acta Oncologica ISSN: 0284-186X / 1651-226X | 🌐Norway | Q3 | CAS Tier 3 | 2.7 | 0.952Q1 | 88 | 186 | 7.4% | Informa Healthcare | Profile |
| 111 | Chinese Clinical Oncology ISSN: 2304-3865 / 2304-3873 | 🌐Hong Kong | Q3 | CAS Tier 4 | 2.7 | 0.636Q2 | — | 48 | 4.8% | AME Publishing Company | Profile |
| 112 | Clinical Breast Cancer ISSN: 1526-8209 / 1938-0666 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.7 | 0.932Q2 | 64 | 146 | 3.4% | Elsevier | Profile |
| 113 | Clinical Colorectal Cancer ISSN: 1533-0028 / 1938-0674 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.7 | 0.976Q2 | 45 | 64 | 0% | Elsevier | Profile |
| 114 | Photodiagnosis and Photodynamic Therapy ISSN: 1572-1000 / 1873-1597 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.7 | 0.609Q2 | 41 | 499 | 19.4% | Elsevier | Profile |
| 115 | Technology in Cancer Research & Treatment ISSN: 1533-0346 / 1533-0338 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.7 | 0.674Q2 | 56 | 256 | 3.7% | SAGE Publications Inc. | Profile |
| 116 | Anti-Cancer Agents in Medicinal Chemistry ISSN: 1871-5206 / 1875-5992 | 🌐United Arab Emirates | Q3 | CAS Tier 4 | 2.6 | 0.584Q3 | 82 | 231 | 3.8% | Bentham Science Publishers B.V. | Profile |
| 117 | Cancer Genomics & Proteomics ISSN: 1109-6535 / 1790-6245 | 🌐Greece | Q2 | CAS Tier 3 | 2.6 | 0.807Q2 | 32 | 61 | 11.5% | International Institute of Anticancer Research | Profile |
| 118 | Cancer Management and Research ISSN: 1179-1322 | 🇺🇸United States | Q3 | CAS Tier 3 | 2.6 | 0.789Q2 | 32 | 814 | 0% | Dove Medical Press Ltd. | Profile |
| 119 | Clinical Medicine Insights-Oncology ISSN: 1179-5549 | 🇬🇧United Kingdom | Q3 | CAS Tier 4 | 2.6 | 0.648Q3 | — | 33 | 0% | Libertas Academica | Profile |
| 120 | ESMO Real World Data and Digital Oncology ISSN: 2949-8201 | 🌐International | Q3 | — | 2.6 | — | — | — | N/A | ELSEVIER | Profile |
| 121 | JMIR Cancer ISSN: 2369-1999 | 🌐Canada | Q3 | CAS Tier 3 | 2.6 | 0.798Q2 | — | 58 | 3% | JMIR Publications | Profile |
| 122 | Thoracic Cancer ISSN: 1759-7706 / 1759-7714 | 🇨🇳China | Q3 | CAS Tier 4 | 2.6 | 0.779Q2 | 20 | 445 | 4.3% | Blackwell Publishing Asia Pty Ltd | Profile |
| 123 | Analytical Cellular Pathology ISSN: 2210-7177 / 2210-7185 | 🇳🇱Netherlands | Q4 | CAS Tier 3 | 2.5 | 0.709Q2 | 18 | 56 | 0% | Hindawi Limited | Profile |
| 124 | Clinical Oncology ISSN: 0936-6555 / 1433-2981 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.5 | 0.926Q1 | 68 | 145 | 6.2% | W.B. Saunders Ltd | Profile |
| 125 | Current Cancer Drug Targets ISSN: 1568-0096 / 1873-5576 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 2.5 | 0.726Q2 | 85 | 70 | 0% | Bentham Science Publishers B.V. | Profile |